Evaluation of the Absence of Intraoperative Bladder Catheterization in Case of Planned Cesarean Section
Condition(s) studied
Investigational drug(s) / intervention(s)
Spontaneous urination during the hour before caesarean section.: Patients will be asked to urinate by spontaneous urination in the hour before the cesarean section with a cytobacteriological urine examination (ECBU) carried out. An ultrasound check by Bladderscan of the post-void residue will be carried out as soon as the patient will be installed on the intervention table. In the event of post-void residue of more than 150 ml, favoring urinary infections, the patient will be excluded from the research.
Systematic bladder catherization during caesarean section.: After implementation of loco-regional analgesia by spinal anesthesia, the patient will be positioned, with a perineal toilet and installation of a bladder catheter type Foley ch. 16.
Study summary
The hypothesis of this trial is that the absence of systematic bladder catheterization in patients performing spontaneous urination in the hour preceding the planned cesarean section under spinal anesthesia would not lead to more bladder heterocatheterization for postpartum urinary retention (RUPP) in the 24 hours post-cesarean section than systematic intraoperative bladder catheterization up to 2 hours post-surgery.
Eligibility
Primary outcome measure(s)
- Necessity of heterocatheterization within 24 hours following the cesarean section. — Between Hour 0 (time of surgical closure) and Hour 24
Heterocatheterization is indicated in cases of Complete postpartum urinary retention (RUPP-C) or in cases of Partial postpartum urinary retention (RUPP-P) with a post-void residue (measured by Bladder scan) greater than the volume urinated (measured in a graduated jar), provided the volume urinated exceeds 150 ml.
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Montpellier University Hospital | Montpellier | France | Recruiting |
| Nîmes University Hospital | Nîmes | France | Recruiting |
More University Hospital, Montpellier trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06357546 on ClinicalTrials.gov ↗ ← All trials in France